An interventional study of zinc gluconate and Placebo in Dysgeusia and Liver Cirrhosis, sponsored by Fundación Clínica Médica Sur. Status unknown at 1 site in Mexico. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-02-15.
Sponsored by Fundación Clínica Médica Sur · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the effect of zinc supplementation in the treatment for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.
Taste disorders are symptomatologies in patients with cirrhosis, these have a direct effect in modification of food consumption, increasing weight loss, anorexia and malnutrition, which impacts in decompensation rates and mortality.
It has been proposed that zinc deficiency is one of the causes for development of taste disorders. The aim of this study is to describe the presence of taste disorders in patients with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste disorders, and in progression of chronic liver disease.
52 studies on the registry are indexed under Dysgeusia; 12 are open to participants now.
This study's planned enrollment of 70 is above the median of 49 across 28 interventional studies indexed under Dysgeusia.
Browse Dysgeusia studies →Fundación Clínica Médica Sur is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
100 mg Placebo plus nutritional education
Dietary Supplement: Placebo · Behavioral: Nutritional education
Nutritional education plus 100 mg of zinc gluconate
Dietary Supplement: zinc gluconate · Behavioral: Nutritional education
Zinc supplementation plus nutritional education
Dysgeusia
Evaluation of presence of any taste disorder, according to questionnaires and evaluation of perception and recognition thresholds with ascending molar concentrations of basic tastes.
Time frame: Presence of any taste disorder at 6 months
This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Gluconic acid
Fundación Clínica Médica Sur